1. Home
  2. WHD vs TVTX Comparison

WHD vs TVTX Comparison

Compare WHD & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

HOLD

Current Price

$47.10

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$34.65

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHD
TVTX
Founded
2011
2008
Country
United States
United States
Employees
N/A
385
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
WHD
TVTX
Price
$47.10
$34.65
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$47.75
$37.21
AVG Volume (30 Days)
525.2K
1.4M
Earning Date
10-29-2025
10-30-2025
Dividend Yield
1.19%
N/A
EPS Growth
N/A
N/A
EPS
2.52
N/A
Revenue
$1,089,969,000.00
$435,826,000.00
Revenue This Year
N/A
$120.36
Revenue Next Year
$33.92
$37.33
P/E Ratio
$18.62
N/A
Revenue Growth
N/A
114.22
52 Week Low
$33.20
$12.91
52 Week High
$65.75
$37.50

Technical Indicators

Market Signals
Indicator
WHD
TVTX
Relative Strength Index (RSI) 71.46 54.03
Support Level $45.06 $34.00
Resistance Level $46.72 $35.79
Average True Range (ATR) 1.60 1.44
MACD 0.35 -0.42
Stochastic Oscillator 95.94 27.78

Price Performance

Historical Comparison
WHD
TVTX

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: